ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,162Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1269

$1.13M Total Retail Price of All Prescriptions

Rank: 11 out of 1269

523 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 523 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 19,802 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 1,118 1,111 1 3
AMLODIPINE BESYLATE 809 806 2 2
METFORMIN HCL 741 712 3 9
LISINOPRIL 710 702 4 1
ZOLPIDEM TARTRATE 575 575 5 19
METOPROLOL SUCCINATE 560 556 6 13
LEVOTHYROXINE SODIUM 516 503 7 4
OMEPRAZOLE 483 483 8 8
HYDROCHLOROTHIAZIDE 481 478 9 10
NEXIUM 469 469 10 41
METOPROLOL TARTRATE 441 440 11 6
DIOVAN 420 416 12 35
ATORVASTATIN CALCIUM 382 366 13 7
CRESTOR 379 379 14 25
ATENOLOL 375 359 15 14
DIOVAN HCT 319 307 16 76
GLIMEPIRIDE 315 303 17 57
WARFARIN SODIUM 308 308 18 12
VYTORIN 279 279 19 168
DICLOFENAC SODIUM 266 264 20 197
FUROSEMIDE 261 261 21 5
AMLODIPINE BESYLATE-BENAZEPRIL 242 226 22 81
FLUTICASONE PROPIONATE 234 231 23 40
ALENDRONATE SODIUM 230 230 24 28
LIPITOR 226 214 25 91
JANUVIA 209 204 26 74
GABAPENTIN 204 184 27 17
LIDODERM 197 197 28 56
ADVAIR DISKUS 163 162 29 46
SYNTHROID 159 159 30 72
MECLIZINE HCL 156 156 31 140
POLYETHYLENE GLYCOL 3350 155 155 32 50
NIFEDIPINE ER 153 153 33 65
PANTOPRAZOLE SODIUM 150 143 34 18
NITROSTAT 135 135 35 191
CARVEDILOL 127 127 36 29
POTASSIUM CHLORIDE 126 126 37 26
LOSARTAN POTASSIUM 124 123 38 15
LUNESTA 124 124 38 269
EXFORGE 120 120 40 181
TRAMADOL HCL 120 119 40 16
CLONIDINE HCL 119 119 42 51
DIGOXIN 117 117 43 62
BENICAR HCT 115 115 44 170
CLOTRIMAZOLE-BETAMETHASONE 115 114 44 175
DONEPEZIL HCL 113 113 46 22
PLAVIX 109 109 47 47
TRIAMTERENE-HCTZ 108 108 48 69
LANSOPRAZOLE 107 102 49 120
IBUPROFEN 105 101 50 73
ZETIA 104 104 51 99
CLOPIDOGREL 103 103 52 32
ESCITALOPRAM OXALATE 96 96 53 58
TAMSULOSIN HCL 95 95 54 31
NITROGLYCERIN PATCH 92 92 55 114
CITALOPRAM HBR 89 87 56 21
TERAZOSIN HCL 88 88 57 111
PRADAXA 88 88 57 281
LOSARTAN-HYDROCHLOROTHIAZIDE 85 85 59 59
VOLTAREN 84 83 60 162
PRAVASTATIN SODIUM 84 80 60 11
LEVOXYL 83 80 62 252
NIFEDICAL XL 82 82 63 138
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 66 64 33
GLIPIZIDE 71 62 64 37
AZITHROMYCIN 68 66 66 42
SERTRALINE HCL 65 61 67 23
BENAZEPRIL HCL 65 65 67 156
NAMENDA 63 63 69 38
IRBESARTAN 63 63 69 219
DILTIAZEM 24HR CD 63 63 69 146
SPIRIVA 62 62 72 64
DEXILANT 61 61 73 200
FINASTERIDE 59 59 74 112
SINGULAIR 57 57 75 123
CLOBETASOL PROPIONATE 57 56 75 245
ALLOPURINOL 56 56 77 49
AVAPRO 56 56 77 369
PROAIR HFA 55 55 79 61
BISOPROLOL FUMARATE 52 52 80 250
ISOSORBIDE MONONITRATE ER 52 52 80 63
ENABLEX 51 51 82 257
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.